UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human Papillomavirus Vaccines

The Journal of infectious diseases, 2021-09, Vol.224 (Supplement_4), p.S367-S378

2021

Volltextzugriff (PDF)

Seroprevalence of Herpes Simplex Virus Types 1 and 2—United States, 1999-2010

The Journal of infectious diseases, 2014-02, Vol.209 (3), p.325-333

2014

Volltextzugriff (PDF)

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs

Vaccine, 2018-08, Vol.36 (32), p.4806-4815

2018

Volltextzugriff (PDF)

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010

The Journal of infectious diseases, 2013-08, Vol.208 (3), p.385-393

2013

Volltextzugriff (PDF)

Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016

Vaccine, 2018-05, Vol.36 (19), p.2567-2573

2018

Volltextzugriff (PDF)

Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017

Vaccine, 2020-11, Vol.38 (47), p.7417-7421

2020

Volltextzugriff (PDF)

Prevalence of HPV Infection among Men: A Systematic Review of the Literature

The Journal of infectious diseases, 2006-10, Vol.194 (8), p.1044-1057

2006

Volltextzugriff (PDF)

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2016007-2016007

2022

Volltextzugriff (PDF)

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003-2006

The Journal of infectious diseases, 2011-08, Vol.204 (4), p.566-573

2011

Volltextzugriff (PDF)

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

The Journal of infectious diseases, 2017-09, Vol.216 (5), p.594-603

2017

Volltextzugriff (PDF)

Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017–March 2020

Vaccine, 2022-05, Vol.40 (20), p.2828-2832

2022

Volltextzugriff (PDF)

The cost-effectiveness of male HPV vaccination in the United States

Vaccine, 2011-10, Vol.29 (46), p.8443-8450

2011

Volltextzugriff (PDF)

Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States

Clinical infectious diseases, 2021-09, Vol.73 (5), p.885-890

2021

Volltextzugriff (PDF)

Prevalence of Genital Human Papillomavirus in Males, United States, 2013–2014

The Journal of infectious diseases, 2017-04, Vol.215 (7), p.1070-1079

2017

Volltextzugriff (PDF)

Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004

The Journal of infectious diseases, 2009-10, Vol.200 (7), p.1059-1067

2009

Volltextzugriff (PDF)

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

Vaccine, 2012-09, Vol.30 (42), p.6016-6019

2012

Volltextzugriff (PDF)

Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States

Clinical infectious diseases, 2018-10, Vol.67 (10), p.1535-1542

2018

Volltextzugriff (PDF)

Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014

The Journal of infectious diseases, 2018-03, Vol.217 (6), p.869-877

2018

Volltextzugriff (PDF)

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

Vaccine, 2015-03, Vol.33 (13), p.1608-1613

2015

Volltextzugriff (PDF)

Human Papillomavirus Vaccine Introduction – The First Five Years

Vaccine, 2012-11, Vol.30, p.F139-F148

2012

Volltextzugriff (PDF)

Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005–2006

The Journal of infectious diseases, 2016-01, Vol.213 (2), p.191-198

2016

Volltextzugriff (PDF)

Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007–2014

Vaccine, 2018-05, Vol.36 (23), p.3381-3386

2018

Volltextzugriff (PDF)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009–2015

Vaccine, 2018-03, Vol.36 (13), p.1781-1788

2018

Volltextzugriff (PDF)

Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014

Journal of acquired immune deficiency syndromes (1999), 2017-07, Vol.75 Suppl 3 (3), p.S370-S374

2017

Volltextzugriff (PDF)

Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model

Vaccine, 2020-11, Vol.38 (50), p.8032-8039

2020

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(134)

Sprache

Englisch
(134)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(134)
Science & Technology
(134)
Humans
(116)
Female
(81)
Infectious Diseases
(79)
Human Papillomavirus
(75)
Microbiology
(71)
Vaccination
(65)
Adolescent
(63)
Adult
(61)
Male
(56)
Biological And Medical Sciences
(53)
Papillomavirus Infections - Prevention & Control
(49)
Vaccines
(47)
Medical Sciences
(43)
Medicine, Research & Experimental
(42)
Research & Experimental Medicine
(42)
Immunization
(39)
Young Adult
(36)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human Papillomavirus Vaccines

Seroprevalence of Herpes Simplex Virus Types 1 and 2—United States, 1999-2010

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010

Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016

Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017

Prevalence of HPV Infection among Men: A Systematic Review of the Literature

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003-2006

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017–March 2020

The cost-effectiveness of male HPV vaccination in the United States

Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States

Prevalence of Genital Human Papillomavirus in Males, United States, 2013–2014

Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States

Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

Human Papillomavirus Vaccine Introduction – The First Five Years

Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005–2006

Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007–2014

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009–2015

Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014

Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model

Aktive Filter

Suchergebnisse filtern